vs
达尔科技（DIOD）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
达尔科技的季度营收约是Orthofix Medical Inc.的1.8倍（$391.6M vs $219.9M），达尔科技净利率更高（2.6% vs -1.0%，领先3.6%），达尔科技同比增速更快（15.4% vs 2.0%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $12.4M），过去两年达尔科技的营收复合增速更高（13.9% vs 8.0%）
达尔科技是一家全球性半导体制造商，主营分立器件、模拟及混合信号半导体产品的设计、生产与销售，产品广泛应用于汽车、工业、消费电子、计算及通信基础设施等核心领域，服务全球各地客户。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
DIOD vs OFIX — 直观对比
营收规模更大
DIOD
是对方的1.8倍
$219.9M
营收增速更快
DIOD
高出13.4%
2.0%
净利率更高
DIOD
高出3.6%
-1.0%
自由现金流更多
OFIX
多$4.4M
$12.4M
两年增速更快
DIOD
近两年复合增速
8.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $391.6M | $219.9M |
| 净利润 | $10.2M | $-2.2M |
| 毛利率 | 31.1% | 71.1% |
| 营业利润率 | 3.4% | 0.2% |
| 净利率 | 2.6% | -1.0% |
| 营收同比 | 15.4% | 2.0% |
| 净利润同比 | 23.8% | 92.4% |
| 每股收益（稀释后） | $0.23 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DIODOFIX
| Q4 25 | $391.6M | $219.9M | ||
| Q3 25 | $392.2M | $205.6M | ||
| Q2 25 | $366.2M | $203.1M | ||
| Q1 25 | $332.1M | $193.6M | ||
| Q4 24 | $339.3M | $215.7M | ||
| Q3 24 | $350.1M | $196.6M | ||
| Q2 24 | $319.8M | $198.6M | ||
| Q1 24 | $302.0M | $188.6M |
净利润DIODOFIX
| Q4 25 | $10.2M | $-2.2M | ||
| Q3 25 | $14.3M | $-22.8M | ||
| Q2 25 | $46.1M | $-14.1M | ||
| Q1 25 | $-4.4M | $-53.1M | ||
| Q4 24 | $8.2M | $-29.1M | ||
| Q3 24 | $13.7M | $-27.4M | ||
| Q2 24 | $8.0M | $-33.4M | ||
| Q1 24 | $14.0M | $-36.0M |
毛利率DIODOFIX
| Q4 25 | 31.1% | 71.1% | ||
| Q3 25 | 30.7% | 72.2% | ||
| Q2 25 | 31.5% | 68.7% | ||
| Q1 25 | 31.5% | 62.8% | ||
| Q4 24 | 32.7% | 69.0% | ||
| Q3 24 | 33.7% | 68.7% | ||
| Q2 24 | 33.6% | 67.8% | ||
| Q1 24 | 33.0% | 67.5% |
营业利润率DIODOFIX
| Q4 25 | 3.4% | 0.2% | ||
| Q3 25 | 3.0% | -8.3% | ||
| Q2 25 | 2.6% | -7.9% | ||
| Q1 25 | 0.4% | -25.2% | ||
| Q4 24 | 3.5% | -5.3% | ||
| Q3 24 | 6.2% | -9.6% | ||
| Q2 24 | 1.2% | -12.5% | ||
| Q1 24 | 4.3% | -15.6% |
净利率DIODOFIX
| Q4 25 | 2.6% | -1.0% | ||
| Q3 25 | 3.6% | -11.1% | ||
| Q2 25 | 12.6% | -6.9% | ||
| Q1 25 | -1.3% | -27.4% | ||
| Q4 24 | 2.4% | -13.5% | ||
| Q3 24 | 3.9% | -13.9% | ||
| Q2 24 | 2.5% | -16.8% | ||
| Q1 24 | 4.6% | -19.1% |
每股收益（稀释后）DIODOFIX
| Q4 25 | $0.23 | $-0.05 | ||
| Q3 25 | $0.31 | $-0.57 | ||
| Q2 25 | $0.99 | $-0.36 | ||
| Q1 25 | $-0.10 | $-1.35 | ||
| Q4 24 | $0.18 | $-0.76 | ||
| Q3 24 | $0.30 | $-0.71 | ||
| Q2 24 | $0.17 | $-0.88 | ||
| Q1 24 | $0.30 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $377.0M | $82.0M |
| 总债务越低越好 | $25.7M | — |
| 股东权益账面价值 | $1.9B | $450.0M |
| 总资产 | $2.4B | $850.6M |
| 负债/权益比越低杠杆越低 | 0.01× | — |
8季度趋势，按日历期对齐
现金及短期投资DIODOFIX
| Q4 25 | $377.0M | $82.0M | ||
| Q3 25 | $386.4M | $62.9M | ||
| Q2 25 | $327.3M | $65.6M | ||
| Q1 25 | $343.9M | $58.0M | ||
| Q4 24 | $316.1M | $83.2M | ||
| Q3 24 | $319.3M | $30.1M | ||
| Q2 24 | $273.9M | $26.4M | ||
| Q1 24 | $276.0M | $27.0M |
总债务DIODOFIX
| Q4 25 | $25.7M | — | ||
| Q3 25 | $24.9M | $157.2M | ||
| Q2 25 | $26.4M | $157.0M | ||
| Q1 25 | $20.5M | $156.9M | ||
| Q4 24 | $20.7M | $157.0M | ||
| Q3 24 | $22.2M | $118.5M | ||
| Q2 24 | $20.3M | $118.0M | ||
| Q1 24 | $20.9M | $118.2M |
股东权益DIODOFIX
| Q4 25 | $1.9B | $450.0M | ||
| Q3 25 | $1.9B | $442.5M | ||
| Q2 25 | $1.9B | $458.3M | ||
| Q1 25 | $1.8B | $458.3M | ||
| Q4 24 | $1.8B | $503.1M | ||
| Q3 24 | $1.8B | $525.9M | ||
| Q2 24 | $1.8B | $546.0M | ||
| Q1 24 | $1.7B | $570.3M |
总资产DIODOFIX
| Q4 25 | $2.4B | $850.6M | ||
| Q3 25 | $2.5B | $832.6M | ||
| Q2 25 | $2.5B | $837.2M | ||
| Q1 25 | $2.4B | $823.1M | ||
| Q4 24 | $2.4B | $893.3M | ||
| Q3 24 | $2.4B | $867.9M | ||
| Q2 24 | $2.4B | $882.0M | ||
| Q1 24 | $2.4B | $906.0M |
负债/权益比DIODOFIX
| Q4 25 | 0.01× | — | ||
| Q3 25 | 0.01× | 0.36× | ||
| Q2 25 | 0.01× | 0.34× | ||
| Q1 25 | 0.01× | 0.34× | ||
| Q4 24 | 0.01× | 0.31× | ||
| Q3 24 | 0.01× | 0.23× | ||
| Q2 24 | 0.01× | 0.22× | ||
| Q1 24 | 0.01× | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $38.1M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $12.4M | $16.8M |
| 自由现金流率自由现金流/营收 | 3.2% | 7.6% |
| 资本支出强度资本支出/营收 | 6.6% | 4.9% |
| 现金转化率经营现金流/净利润 | 3.74× | — |
| 过去12个月自由现金流最近4个季度 | $137.2M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流DIODOFIX
| Q4 25 | $38.1M | $27.7M | ||
| Q3 25 | $79.1M | $12.4M | ||
| Q2 25 | $41.5M | $11.6M | ||
| Q1 25 | $56.7M | $-18.4M | ||
| Q4 24 | $81.8M | $23.7M | ||
| Q3 24 | $54.4M | $11.7M | ||
| Q2 24 | $14.4M | $9.0M | ||
| Q1 24 | $-31.1M | $-18.6M |
自由现金流DIODOFIX
| Q4 25 | $12.4M | $16.8M | ||
| Q3 25 | $62.8M | $2.5M | ||
| Q2 25 | $21.1M | $4.5M | ||
| Q1 25 | $40.8M | $-25.1M | ||
| Q4 24 | $62.1M | $15.2M | ||
| Q3 24 | $39.4M | $6.3M | ||
| Q2 24 | $-3.5M | $-360.0K | ||
| Q1 24 | $-51.5M | $-29.1M |
自由现金流率DIODOFIX
| Q4 25 | 3.2% | 7.6% | ||
| Q3 25 | 16.0% | 1.2% | ||
| Q2 25 | 5.8% | 2.2% | ||
| Q1 25 | 12.3% | -13.0% | ||
| Q4 24 | 18.3% | 7.0% | ||
| Q3 24 | 11.2% | 3.2% | ||
| Q2 24 | -1.1% | -0.2% | ||
| Q1 24 | -17.1% | -15.4% |
资本支出强度DIODOFIX
| Q4 25 | 6.6% | 4.9% | ||
| Q3 25 | 4.2% | 4.8% | ||
| Q2 25 | 5.6% | 3.5% | ||
| Q1 25 | 4.8% | 3.5% | ||
| Q4 24 | 5.8% | 4.0% | ||
| Q3 24 | 4.3% | 2.7% | ||
| Q2 24 | 5.6% | 4.7% | ||
| Q1 24 | 6.7% | 5.6% |
现金转化率DIODOFIX
| Q4 25 | 3.74× | — | ||
| Q3 25 | 5.54× | — | ||
| Q2 25 | 0.90× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 9.93× | — | ||
| Q3 24 | 3.95× | — | ||
| Q2 24 | 1.80× | — | ||
| Q1 24 | -2.22× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DIOD
| Distributor | $253.1M | 65% |
| Direct Sales | $138.5M | 35% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
